Call for proposals for hospital-based clinical research projects devoted to emerging and re-emerging infectious diseases
Last updated on 17 November 2026
The ReCH-MIE call for proposals aims to support applied clinical research projects in hospital settings. It covers all emerging or re-emerging pathogens, including multidrug-resistant bacteria and fungi.
The call covers research applied to patient care and healthcare provision, with two main objectives:
Following the scientific assessment process, conducted by an independent expert committee led by ANRS MIE, 11 of the 23 eligible projects were recommended for funding by the expert committee, for a maximum total amount of €9,283,365.
ANRS MIE warmly thanks all the applicant teams, as well as the experts involved in this process.
Selected projects – Ministry of Health website|
Project leader |
Healthcare institution managing the funds |
Project name |
Project title |
|
CAMBAU Emmanuelle |
Greater Paris University Hospitals (AP-HP) |
IDENOMY |
Characterisation of immune deficiencies in patients with non-tuberculous mycobacterial (NTM) infection: a feasibility study |
|
DE LA PORTE DES VAUX Clémentine |
Greater Paris University Hospitals (AP-HP) |
CAPSIDE |
Pilot and feasibility study for detecting resistant or emerging skin-mediated infections and assessing health status among homeless adults in Paris. |
|
DUVAL Xavier |
Greater Paris University Hospitals (AP-HP) |
REMAP-IE |
A network-based adaptive platform for therapeutic trials in infective endocarditis |
|
LE GOFF Jerome |
Greater Paris University Hospitals (AP-HP) |
VIR-HOST-PREDICT |
Early prediction of complications of respiratory viral infections in immunocompromised patients |
|
CHAÏBI Khalil |
Greater Paris University Hospitals (AP-HP) |
PACIFIC-VAP |
Determinants of the transition from colonisation to Pseudomonas aeruginosa infection in ventilated intensive care patients |
|
BOHARD Louis |
Besançon University hospital |
BioMEK |
Relevance of novel biomarkers for monitoring cystic echinococcosis |
|
KERNEIS Solen |
Greater Paris University Hospitals (AP-HP) |
SCORE |
Impact of real-time genomic sequencing on controlling the transmission of emerging highly resistant bacteria (BHRe) in healthcare settings: a pragmatic cluster-randomised trial |
|
ROQUILLY Antoine |
Nantes University Hospital |
SHAPe-IFIX |
Infliximab for the treatment of severe hospital-acquired pneumonia at high risk of antibiotic-resistant bacteria: a phase II randomised, double-blind, placebo-controlled clinical trial, a component of the SHAPe factorial platform trial |
|
MELICA Giovanna |
Greater Paris University Hospitals (AP-HP) |
TRANSVAC-RSV |
Immunogenicity and safety of a booster vaccine dose 12 months after an initial dose of an mRNA or adjuvanted protein-based RSV pre-F vaccine in kidney transplant recipients: a phase II randomised, parallel-group superiority trial |
|
GUEDJ Jérémie |
Greater Paris University Hospitals (AP-HP) |
BALOPEP |
Efficacy of baloxavir prophylaxis against influenza virus transmission and influenza infection among nursing home residents |
|
NOEL Nicolas |
Greater Paris University Hospitals (AP-HP) |
OptiViRes |
Optimisation of care pathways for patients with respiratory viral infections through nasopharyngeal interferon phenotyping in primary care |
Discover the laureate projects from the previous edition.
2024 laureates